Intended Use

The Imagio Breast Imaging System is indicated for evaluation of palpable and non-palpable breast abnormalities in adult patients referred for diagnostic breast imaging work-up, combining ultrasound and optoacoustic imaging with an AI-based tool to assist in mass classification.

Technology

The device integrates pulsed laser optoacoustic imaging with conventional ultrasound imaging, using dual near-infrared wavelengths to estimate hemoglobin oxygen saturation in breast tissue. It acquires co-registered structural ultrasound and functional optoacoustic images in real-time with a handheld probe and utilizes a machine learning software tool (SenoGram) to assist users in assessing BI-RADS classification and malignancy probability from reader-input feature scores.

Performance

Performance testing included extensive nonclinical laboratory validation for image quality, spatial resolution, co-registration accuracy, and oxygen saturation measurement. A pivotal multi-reader, multi-case clinical study (Reader-02) using data from over 1900 patients demonstrated that adding optoacoustic imaging to ultrasound significantly improved specificity for breast mass classification at a fixed 98% sensitivity. The AI-based SenoGram software showed high sensitivity (97.0%) and improved specificity (50.9%) in detecting malignancy. Safety data indicate low rates of mild adverse events and no serious adverse device effects.

Ready to Sharpen Your Edge?

Subscribe to join 7,600+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.